Amlodipine/atorvastatin for preventing heart disease.

摘要

The STEPS department on amlodipine/atorvastatih (Caduet) in the March 15, 2006, issue of American Family Physician,contains several misleading statements that contradict available evidence.First, the article states: "Amlodipine.. .has not been shown to reduce the risks of myo-cardial infarction, stroke, or death."1 In ALLHAT, amlodipine was as efficacious as chlorthalidone (Hygroton) in reducing the risk of myocardial infarction, stroke, and death. Amlodipine was more efficacious in reducing strokes than was lisinopril (Zestril).